%PDF-1.4
%
1 0 obj
<>>>/Pages 3 0 R/Type/Catalog>>
endobj
427 0 obj
<>stream
2017-06-29T12:05:04+01:00
Arbortext Advanced Print Publisher 9.0.215/W Unicode
2024-03-28T01:49:02-07:00
2024-03-28T01:49:02-07:00
GPL Ghostscript 9.15
application/pdf
Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study
uuid:bc56cd66-1dd1-11b2-0a00-5e0827bd3700
uuid:bc56cd6a-1dd1-11b2-0a00-5b0000000000
endstream
endobj
3 0 obj
<>
endobj
4 0 obj
<>/ExtGState<>/Font<>/Pattern<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Type/Page>>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Type/Page>>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Type/Page>>
endobj
8 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Type/Page>>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Type/Page>>
endobj
458 0 obj
<>stream
HW[oF~#_ rAfm}.4H⨿ߙ!mJ[{,P(̜9#6W.=z5a++erJ;'їLSc|.|^x*RL?sQRIvх)g1bIt̵q>o?7痡+ݲ.`ǚI咾V`e^hGBh5\3%l[7aхG<^O/9"1^%[UeRTprUm{;?y~-\t.I~IT.IiyeKAhFe!gMYkDBI|'$`LLy#s\ͤT<}uImm>8f3ڜU
˕Oo+;Ό>j^O |X6r&Nb_{ E
ʍe.M *wrfP Qݡn ,$+R;ڮE\ xʭڇVp-иגLsLf3.(pSv.35ZrI9
X :k3XVe"X=A҇Yn\%Jiv`f< tWv+lp%C-]כU*֛SfGY4~+#h